Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 2, 2014
Safety and effectiveness of bevacizumab treatment for metastatic colorectal cancer: final results from the Avastin(®) Registry - Investigation of Effectiveness and Safety (ARIES) observational cohort studyH I Hurwitz, T S Bekaii-Saab, J C Bendell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePTH S Hochster, A Grothey, L Hart, et al.
Oncogene|August 8, 2012
LMTK3 is implicated in endocrine resistance via multiple signaling pathwaysJ Stebbing, A Filipovic, L C Lit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2018
The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?A Sobrero, A Grothey, T Iveson, et al.
ESMO Open|December 13, 2021
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC studyJ Tabernero, L Velez, T L Trevino, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of i.v. CI-980 in patients with advanced platinum refractory epithelial ovarian carcinomaA P Kudelka, A Hasenburg, C F Verschraegen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studiesJ Taieb, Q Shi, L Pederson, et al.
Oncogene|June 10, 2014
KSR1 regulates BRCA1 degradation and inhibits breast cancer growthJ Stebbing, H Zhang, Y Xu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2015
Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†L A Renfro, A Grothey, D Kerr, et al.
Investigational New Drugs|October 12, 2013
UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabineMatthew P Goetz, Heidi A McKean, Joel M Reid, et al.
Pageof 5